BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37046121)

  • 1. Optical coherence tomography combined with convolutional neural networks can differentiate between intrahepatic cholangiocarcinoma and liver parenchyma ex vivo.
    Wolff LI; Hachgenei E; Goßmann P; Druzenko M; Frye M; König N; Schmitt RH; Chrysos A; Jöchle K; Truhn D; Kather JN; Lambertz A; Gaisa NT; Jonigk D; Ulmer TF; Neumann UP; Lang SA; Amygdalos I
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7877-7885. PubMed ID: 37046121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography and convolutional neural networks can differentiate colorectal liver metastases from liver parenchyma ex vivo.
    Amygdalos I; Hachgenei E; Burkl L; Vargas D; Goßmann P; Wolff LI; Druzenko M; Frye M; König N; Schmitt RH; Chrysos A; Jöchle K; Ulmer TF; Lambertz A; Knüchel-Clarke R; Neumann UP; Lang SA
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3575-3586. PubMed ID: 35960377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.
    Wang T; Kong J; Yang X; Shen S; Zhang M; Wang W
    J Surg Oncol; 2020 Mar; 121(3):524-537. PubMed ID: 31867746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed Tomography Radiomics to Differentiate Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
    Mahmoudi S; Bernatz S; Ackermann J; Koch V; Dos Santos DP; Grünewald LD; Yel I; Martin SS; Scholtz JE; Stehle A; Walter D; Zeuzem S; Wild PJ; Vogl TJ; Kinzler MN
    Clin Oncol (R Coll Radiol); 2023 May; 35(5):e312-e318. PubMed ID: 36804153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma.
    Xiao Y; Zhou C; Ni X; Huang P; Wu F; Yang C; Zeng M
    Cancer Imaging; 2023 Feb; 23(1):15. PubMed ID: 36782276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting very early recurrence in intrahepatic cholangiocarcinoma after curative hepatectomy using machine learning radiomics based on CECT: A multi-institutional study.
    Chen B; Mao Y; Li J; Zhao Z; Chen Q; Yu Y; Yang Y; Dong Y; Lin G; Yao J; Lu M; Wu L; Bo Z; Chen G; Xie X
    Comput Biol Med; 2023 Dec; 167():107612. PubMed ID: 37939408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
    Rhee H; Kim MJ; Park YN; An C
    Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-based deep learning enables early postoperative recurrence prediction for intrahepatic cholangiocarcinoma.
    Wakiya T; Ishido K; Kimura N; Nagase H; Kanda T; Ichiyama S; Soma K; Matsuzaka M; Sasaki Y; Kubota S; Fujita H; Sawano T; Umehara Y; Wakasa Y; Toyoki Y; Hakamada K
    Sci Rep; 2022 May; 12(1):8428. PubMed ID: 35590089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic cholangiocarcinoma - influence of resection margin and tumor distance to the liver capsule on survival.
    Bartsch F; Baumgart J; Hoppe-Lotichius M; Straub BK; Heinrich S; Lang H
    BMC Surg; 2020 Apr; 20(1):61. PubMed ID: 32252724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-energy CT based material decomposition to differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
    Mahmoudi S; Bernatz S; Althoff FC; Koch V; Grünewald LD; Scholtz JE; Walter D; Zeuzem S; Wild PJ; Vogl TJ; Kinzler MN
    Eur J Radiol; 2022 Nov; 156():110556. PubMed ID: 36270195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning radiomics can predict early liver recurrence after resection of intrahepatic cholangiocarcinoma.
    Jolissaint JS; Wang T; Soares KC; Chou JF; Gönen M; Pak LM; Boerner T; Do RKG; Balachandran VP; D'Angelica MI; Drebin JA; Kingham TP; Wei AC; Jarnagin WR; Chakraborty J
    HPB (Oxford); 2022 Aug; 24(8):1341-1350. PubMed ID: 35283010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.
    Regimbeau JM; Panis Y; Nemeth J; Pocard M; de Claviere G; Soyer P; Valleur P
    Hepatogastroenterology; 2003; 50(49):21-3. PubMed ID: 12629982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma.
    Sposito C; Ratti F; Cucchetti A; Ardito F; Ruzzenente A; Di Sandro S; Maspero M; Ercolani G; Di Benedetto F; Guglielmi A; Giuliante F; Aldrighetti L; Mazzaferro V
    J Hepatol; 2023 Feb; 78(2):356-363. PubMed ID: 36328332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of three-dimensional imaging in operative planning for hilar cholangiocarcinoma.
    Endo I; Shimada H; Sugita M; Fujii Y; Morioka D; Takeda K; Sugae S; Tanaka K; Togo S; Bourquain H; Peitgen HO
    Surgery; 2007 Nov; 142(5):666-75. PubMed ID: 17981186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery and hepatic artery infusion therapy for intrahepatic cholangiocarcinoma.
    Scott A; Wong P; Melstrom LG
    Surgery; 2023 Jul; 174(1):113-115. PubMed ID: 36906437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcomatoid intrahepatic cholangiocarcinoma in a patient with poor prognosis: a case report and literature review.
    Li X; Li J; Liu K; Tan L; Liu Y
    J Int Med Res; 2020 Nov; 48(11):300060520969473. PubMed ID: 33161814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Benign hilar bile duct stricture resected as perihilar cholangiocarcinoma].
    Nagino M; Ebata T; Otsuka S
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(8):679-688. PubMed ID: 32779585
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of CT during arterial portography for preoperative diagnosis of intrahepatic cholangiocarcinoma.
    Miura F; Okazumi S; Takayama W; Asano T; Makino H; Shuto K; Ochiai T; Takada T; Yasuda H; Nagashima I; Amano H; Yoshida M
    Hepatogastroenterology; 2006; 53(69):435-7. PubMed ID: 16795987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiofrequency ablation of recurrent intrahepatic cholangiocarcinoma: a case report].
    Genov I; Grigorov N; Mitova R; Golemanov B; Dinkov L
    Khirurgiia (Sofiia); 2005; (4-5):45-7. PubMed ID: 18693517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management.
    El Rassi ZE; Partensky C; Scoazec JY; Henry L; Lombard-Bohas C; Maddern G
    Eur J Surg Oncol; 1999 Aug; 25(4):375-80. PubMed ID: 10419707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.